To provide a comprehensive overview of published case reports for genetic mitochondrial disease (GMD) patients undergoing anesthetic exposures, emphasizing types of procedures and reported complications.
Approach:
Case Report Identification: PubMed was searched for relevant case reports on anesthesia in GMD patients, yielding 148 cases from 123 reports.
Complication Assessment: Complications were categorized into three severity levels: mild, moderate, and severe, based on clinical outcomes.
Statistical Analysis: Descriptive and inferential statistics were used to examine relationships between complications and various factors, acknowledging limitations in data quality.
Key Findings:
GMDs affect approximately 1 in 4000 individuals and exhibit significant genetic and clinical heterogeneity.
Patients with GMD may show hypersensitivity to volatile anesthetic agents, particularly linked to mitochondrial electron transport chain complex I defects.
Anesthetic exposure in GMD patients can lead to a range of complications, including metabolic changes, neurodegenerative disease acceleration, and potential death.
Interpretation:
The review highlights the risks associated with general anesthesia in GMD patients.
Limitations:
The heterogeneity of case reports limits robust statistical analysis.
Insufficient data on long-term outcomes post-anesthesia complicates the assessment of anesthetic impact on disease progression.
Conclusion:
Further research is needed to understand the management of anesthetic procedures in patients with GMD.
The new option is indicated for CMV prophylaxis in pediatric kidney and heart transplant recipients, as well as adult CMV retinitis and transplant prophylaxis.
